KVUE Company Profile and Key Details

KVUE has shown sold momentum, gaining 3.47% over the past week and 15.04% over the past quarter, though year-to-date performance is up 1.97%. Short-term trend indicators are mixed aligned (SMA20 3.69%, SMA50 7.64%, SMA200 0.16%). The stock’s 14-day RSI is 66.65 (firm momentum), while the ATR of 0.36 points to higher daily volatility. The stock remains hovering near 52-week lows, trading -24.51% below its high and over 35.52% above its low. Average 10-day trading volume of 18.72 million shares is below the 3-month average of 40.98 million, indicating normal recent market interest.

Kenvue Inc. (NYSE:KVUE) closed at $17.14 USD, losing -$0.24 (-1.38%) from the previous close of $17.38. The stock is currently mid-range between its 52-week high and low $14.02 and $25.17. With a market capitalization of about $32.85 billion, Kenvue Inc. is classified as a large-cap and shows lower-than-market volatility (beta ~0.47). Key stats such as the average daily volume over the past year has been around 40.88 million shares, volume is running light vs its 52-week average. Headquartered in Summit, NJ, Kenvue Inc. operates in the Consumer Defensive sector and the Household & Personal Products industry. Led by CEO Kirk L. Perry, the company employs approximately 22,000 people and listed since May 04, 2023. Kenvue Inc. operates as a consumer health company worldwide.

Kenvue Inc. has 1.92 billion shares outstanding. The public float is 1.92 billion shares, elevated short interest at 2.52% of float. This equals 36.45 million shares. The short ratio is 1.97 days. Institutional investors hold 102.01% of the float. Insiders own 0.04%. Smith Jeffrey C holds 27.31 million shares, Lawson Carlton has 56.32 thousand shares and ALLISON RICHARD E JR has 25.60 thousand shares. Over the past six months, insider transactions show net buying. They sold 0.00 shares across 0 transactions.

Kenvue Inc. last paid a dividend of 0.83 per share, Dividend and splits history remains an important factor for investors monitoring long-term returns. A discounted cash flow model estimates fair value at around $51.97. This means the shares are trading below this model’s fair value.

Wall Street analysts project EPS growth of 5.66% annually over the next five years. The latest quarter delivered EPS of $0.28. The next quarter is forecast at $0.26. Next year's EPS is expected at $0.47. Analyst sentiment is neutral. Analyst rating data shows there are 2 Strong Buy ratings, 5 Buy ratings, 21 Hold ratings, 0 Sell rating and 0 Strong Sell ratings. Price targets range from $26.00 to $15.00. The high target offers 51.69% upside. The low target suggests -12.49% downside. The mean target is $20.80. This offers 21.35% upside. Kenvue Inc. earnings surprise history is a consistent trend of beating forecasts. The quarter that ended November 03, 2025, missed forecasts by 7.61%. The prior quarter beat by 2.95%. Over the last six quarters, Apple has recorded several small beats. These include 16.07% in August 06, 2024.

Kenvue Inc. trades at a P/E ratio of 22.41, slightly below the S&P 500 average, with a price-to-sales ratio of 2.18 and a price-to-book ratio of 3.06 trading at moderately above to book value. The P/FCF stands at 19.14, also above market averages.

Kenvue Inc. (NYSE:KVUE) shares are flat 1.97% year-to-date currently trading near 52-week highs band. Short-term momentum has been positive over the last quarter, despite recent volatility. Valuation shows Kenvue Inc. trading at a premium to the broader market with a P/E of 22.41. Analyst sentiment is cautious, with the majority of ratings in Equal-Weight territory and a mean price target of $22.39, suggesting 30.63% upside. Our AI forecast model points to short-term weakness (-1.17% over two weeks), a medium-term rise (19.14% over three months), and a longer-term loss (-3.5% over one year), with expected trading ranges indicating moderate volatility.

Our AI price prediction model suggests that Kenvue Inc. stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term. 2-Week Outlook: Projected decline of -1.17%, with price expected at $16.94 by April 16, 2026, within a range of $16.57 to $17.33 3-Month Outlook: Projected rise of 19.14%, reaching $20.42 by July 01, 2026, with a range of $19.35 to $21.44. 1-Year Outlook: Projected loss of -3.5%, with price at $16.54 by April 02, 2027, within a range of $15.61 to $17.37.